Skip to main content
SpringerLink
Log in

Was ist die optimale Dauer der Triple-Therapie bei Patienten mit Vorhofflimmern nach DES?

Which duration of triple therapy is ideal for patients with atrial fibrillation after DES?

  • Journal Club
  • Published:
Der Kardiologe Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Literatur

  1. Fiedler KA, Maeng M, Mehilli J et al (2015) Duration of triple therapy in patients requiring oral anticoagulation after drug-eluting stent implantation: The ISAR-TRIPLE Trial. J Am Coll Cardiol 65:1619–1629

    Article  PubMed  Google Scholar 

  2. Faxon DP, Eikelboom JW, Berger PB et al (2011) Antithrombotic therapy in patients with atrial fibrillation undergoing coronary stenting: a North American perspective: executive summary. Circ Cardiovasc Interv 4:522–534

    Article  PubMed  Google Scholar 

  3. Windecker S, Hernandez-Antolin RA, Stefanini GG et al (2014) Management of ST-elevation myocardial infarction according to European and American guidelines. Eurointervention 10 Suppl T:T23–31

    Article  Google Scholar 

  4. Dewilde WJ, Oirbans T, Verheugt FW et al (2013) Use of clopidogrel with or without aspirin in patients taking oral anticoagulant therapy and undergoing percutaneous coronary intervention: an open-label, randomised, controlled trial. Lancet 381:1107–1115

    Article  CAS  PubMed  Google Scholar 

  5. Bhatt DL (2015) When is a double better than a TRIPLE? Stenting patients with atrial fibrillation. J Am Coll Cardiol 65:1630–1632

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Klinikum VEST, Knappschaftskrankenhaus Recklinghausen, Dorstener Strasse 151, 45657, Recklinghausen, Deutschland

    C. Özcelik

Authors
  1. C. Özcelik
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to C. Özcelik.

Ethics declarations

Interessenkonflikt

C. Özcelik gibt an, dass kein Interessenkonflikt besteht.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Özcelik, C. Was ist die optimale Dauer der Triple-Therapie bei Patienten mit Vorhofflimmern nach DES?. Kardiologe 9, 281–282 (2015). https://doi.org/10.1007/s12181-015-0010-z

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12181-015-0010-z

Search

Navigation